StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
Huagongshe Open Project:[email protected]KI-Anbindung: llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.7.8
Zurück
HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
HCID 353443Erstellt: 27. Oktober 2026

2-Methoxy-1-Pyrroline

3,4-dihydro-5-methoxy-2H-Pyrrole · c-C4H6N(2-OCH3) · 2-methoxypyrrole · AKOS BBS-00007016 · 2-METHOXY-1-PYRROLINE · Tipiracil Impurity 16 · 2-Methoxy-1-pyrrolidine · Piracetam EP Impurity 5

https://huagongshe.com/de/chemical/353443

Molekülstruktur von 2-Methoxy-1-Pyrroline

Identifikatoren & physikalische Daten

CAS No.5264-35-7
SummenformelC5H9NO
Durchschnittliche Molmasse99,13 g/mol
Monoisotopische Masse99,06841391 g/mol
SMILESCOC1=NCCC1
InChIKeyQYGNDKJRRNVSEC-UHFFFAOYSA-N
PubChem CID353443
EC No.671-815-2
DTXSIDDTXSID90326564

Chemische & physikalische Eigenschaften

XLogP0,1
Polarare Oberfläche (TPSA)21,6
H-Brücken-Donoren0
H-Brücken-Akzeptoren2
Frei drehbare Bindungen1
Schwere Atome7
Formalladung0
Komplexität88,1
Siedepunkt118-121 °C
Dichte1.05±0.1 g/cm3(Predicted)
Brechungsindex1.4375
Lagerbedingungen2-8°C
pKa (Säurekonstante)6.29±0.20(Predicted)
InChIInChI=1S/C5H9NO/c1-7-5-3-2-4-6-5/h2-4H2,1H3
InChIKeyQYGNDKJRRNVSEC-UHFFFAOYSA-N
SMILESN1=C(OC)CCC1

Sicherheit & Vorschriften

GHS-EinstufungWarningH226 (33.3%): Flammable liquid and vapor [Warning Flammable liquids]P210, P233, P240, P241, P242, P243, P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P303+P361+P353, P304+P340, P305+P351+P338, P317, P319, P321, P330, P332+P317, P337+P317, P362+P364, P370+P378, P403+P233, P403+P235, P405, and P501 (click each P-code to see the statement)Aggregated GHS information provided per 3 reports by companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Hazard Classes and CategoriesFlam. Liq. 3 (33.3%)
GefahrenklasseIRRITANT

Anwendungen & Verwendung

Verwenden

2-Methoxy-1-pyrroline acts as a reagent in the design and preparation of dihydroindolones and dihydroindolizinones as orally available MEK inhibitors with potent in vivo antitumor efficacy. Synthesis and anti-HSV activity of methylenedioxy mappicine ketone analogs against herpes viruses.